Scientists at ETH Zurich have identified a compound that sharply reduced nerve-cell death in mice engineered to develop ...

Creative Biolabs’ integrated workflow addresses challenges in anti-glycopeptide antibody discovery, including weak ...

Colorectal cancer (CRC) remains one of the most heterogeneous malignancies, with substantial variability in molecular ...

PS, designed entirely by artificial intelligence, passed its first human safety trial at Cambridge — triggering ...